Post-Pandemic Seroprevalence of 2009 Pandemic Influenza A (H1N1) Virus in Shandong Province, China

The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was c...

Full description

Saved in:
Bibliographic Details
Published inJapanese Journal of Infectious Diseases Vol. 65; no. 5; pp. 410 - 414
Main Authors Wang, Yulu, Xu, Aiqiang, Zhang, Shengyang, Wang, Shuang, Wang, Xianjun, Lin, Yi, Bi, Zhenqiang, Liu, Ti, Song, Shaoxia, Li, Zhong
Format Journal Article
LanguageEnglish
Published Japan National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee 2012
Subjects
Online AccessGet full text
ISSN1344-6304
1884-2836
1884-2836
DOI10.7883/yoken.65.410

Cover

Abstract The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0–5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies.
AbstractList The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85z. The seropositive rate was 25.89z for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0-5 years and elderly people aged > or =60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26z of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies.
The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0–5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies.
The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0-5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies.The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09] infection in Shandong Province, China and to identify the influencing factors. A randomized serological survey of A(H1N1)pdm09 infection was carried out in August and September 2010. A total of 4,549 participants involved in the survey had their antibody levels tested by hemagglutination-inhibition assay. The overall seropositive rate for A(H1N1)pdm09 antibodies was 25.85%. The seropositive rate was 25.89% for the unvaccinated group, with statistically significant differences among individuals of different age groups, occupations, and cities. The highest seropositive rate was observed in young children aged 0-5 years and elderly people aged ≥60 years. Multivariate logistic regression revealed that subjects in rural areas had significantly higher odds ratio of A(H1N1)pdm09 seropositivity than those in the capital city. Individuals belonging to all professions, except for teachers, had significantly lower odds ratio of A(H1N1)pdm09 seropositivity compared with children in family care. Our data indicated that almost 26% of the residents in Shandong Province had appropriate antibody titers against A(H1N1)pdm09. This seroepidemiology study provides valuable data for understanding the epidemiology of the 2009 pandemic influenza and for planning future intervention strategies; moreover, it highlights the significance of seroprevelance studies.
Author Song, Shaoxia
Wang, Xianjun
Wang, Yulu
Li, Zhong
Liu, Ti
Zhang, Shengyang
Wang, Shuang
Xu, Aiqiang
Lin, Yi
Bi, Zhenqiang
Author_xml – sequence: 1
  fullname: Wang, Yulu
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Xu, Aiqiang
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Zhang, Shengyang
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Wang, Shuang
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Wang, Xianjun
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Lin, Yi
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Bi, Zhenqiang
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Liu, Ti
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Song, Shaoxia
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
– sequence: 1
  fullname: Li, Zhong
  organization: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Diseases Control and Prevention, Shandong University Institute for Prevention Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22996214$$D View this record in MEDLINE/PubMed
BookMark eNqF0c1rFDEYBvAgFfuhN88lxwqdNd-TnKQsagtFF6peQyZ9002dTbbJTKH-9U676woF8ZTA-3uSkOcQ7aWcAKG3lMxarfn7h_wT0kzJmaDkBTqgWouGaa72pj0XolGciH10WOstIUxKSl6hfcaMUYyKA9Qtch2ahUvXsIoeX0HJ6wL3rofkAeeAGSEG7-YXKfQjpF8On-GTc_qFvsM_YhkrjglfLSeV0w1elHwfp_gpni9jcq_Ry-D6Cm-26xH6_unjt_l5c_n188X87LLx0rChaV3QznM1PdIHqbzuoGWkNarrfCCMtsY5GoQ3mmoTghCd9IJQL3krWsEMP0Inm3PXJd-NUAe7itVD37sEeayWSi60bFtD_0-JMoxIzdREj7d07FZwbdclrlx5sH--cAKnG-BLrrVA2BFK7GND9qkhq6SdGpo4e8Z9HNwQcxqKi_2_Qh82ods6uBvY3eDKEH0Pf7HcJnYTv3TFQuK_AadvqaA
CitedBy_id crossref_primary_10_1007_s00705_016_2997_2
crossref_primary_10_1155_2022_5833769
Cites_doi 10.1371/journal.pone.0011601
10.1371/journal.pone.0023034
10.2807/ese.14.18.19204-en
10.3201/eid1701.100014
10.1086/656922
10.1371/journal.pone.0024440
10.1016/j.vaccine.2010.03.006
10.1056/NEJMoa0911530
10.1016/S0140-6736(09)62126-7
10.1371/journal.pone.0012562
10.1186/1471-2458-10-650
10.1056/NEJMoa0906453
10.1371/journal.pone.0013211
ContentType Journal Article
Copyright Authors
Copyright_xml – notice: Authors
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T2
7U1
7U9
C1K
H94
DOI 10.7883/yoken.65.410
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Health and Safety Science Abstracts (Full archive)
Risk Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Risk Abstracts
AIDS and Cancer Research Abstracts
Health & Safety Science Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList Risk Abstracts

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1884-2836
EndPage 414
ExternalDocumentID 22996214
10_7883_yoken_65_410
article_yoken_65_5_65_410_article_char_en
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
China, People's Rep., Shandong Prov
GeographicLocations_xml – name: China
– name: China, People's Rep., Shandong Prov
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
7.U
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
JSF
JSH
KQ8
OK1
OVT
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T2
7U1
7U9
C1K
H94
ID FETCH-LOGICAL-c592t-7af8ac36025cf56c8be720796bbcf02179aa1f4c98189ff44b5c401c537474293
ISSN 1344-6304
1884-2836
IngestDate Thu Jul 10 18:37:02 EDT 2025
Fri Jul 11 02:47:10 EDT 2025
Mon Jul 21 06:03:49 EDT 2025
Tue Jul 01 03:55:09 EDT 2025
Thu Apr 24 23:11:50 EDT 2025
Wed Sep 03 06:30:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c592t-7af8ac36025cf56c8be720796bbcf02179aa1f4c98189ff44b5c401c537474293
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://www.jstage.jst.go.jp/article/yoken/65/5/65_410/_article/-char/en
PMID 22996214
PQID 1069205826
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_1534857791
proquest_miscellaneous_1069205826
pubmed_primary_22996214
crossref_primary_10_7883_yoken_65_410
crossref_citationtrail_10_7883_yoken_65_410
jstage_primary_article_yoken_65_5_65_410_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-00-00
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – year: 2012
  text: 2012-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Japanese Journal of Infectious Diseases
PublicationTitleAlternate Jpn J Infect Dis
PublicationYear 2012
Publisher National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
Publisher_xml – name: National Institute of Infectious Diseases, Japanese Journal of Infectious Diseases Editorial Committee
References 10. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveillance, 14, pii=19365.
8. Zimmer, S.M., Crevar, C.J., Carter, D.M., et al. (2010): Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE, 5, e11601.
5. Centers for Disease Control and Prevention (2009): Swine-origin influenza A (H1N1) virus infections in a school—New York City, April 2009. Mobid. Mortal. Wkly. Rep., 58, 470–472.
12. Xu, C., Bai, T., Iuliano, A.D., et al. (2010): The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One, 6, e17919.
26. Wu, U.I., Liu, M.T., Wang, J.T., et al. (2010): Serological response to H1N1 influenza virus infections in adults treated with oseltamivir. Clin. Infect. Dis., 51, 1223–1225.
29. Hancock, K., Veguilla, V., Lu, X., et al. (2009): Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med., 361, 1945–1952.
9. Tilston, N.L., Eames, K.T., Paolotti, D., et al. (2010): Internetbased surveillance of influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health, 10, 650.
31. Rizzo, C., Rota, M.C., Bella, A., et al. (2010): Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine, 28, 3558–3562.
28. Ross, T.M., Hairong, L., Chia, B.S., et al. (2011): Prevalence of antibodies against seasonal influenza A and B viruses during the 2009–2010 and 2010–2011 influenza seasons in residents of Pittsburgh, PA, USA. PLoS Currents Influenza, 2011 Oct 25.
30. Huang, D.T., Shao, P.L., Huang, K.C., et al. (2011): Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerg. Infect. Dis., 17, 76–78.
14. Word Health Organization (WHO): WHO Manual on animal influenza diagnosis and surveillance WHO/CDS/CSR/NCS/2002.5. Online at 〈http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf〉.
22. Achonu, C., Rosella, L., Gubbay, J.B., et al. (2011): Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009–May 2010. PLoS One, 6, e26427.
24. von Kries, R., Weiss, S., Falkenhorst, G., et al. (2011): Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children, 18 years in Germany. PLoS One, 6, e23955.
15. Cowling, B.J., Chan, K.H., Fang, V.J., et al. (2010): Comparative epidemiology of pandemic and seasonal influenza A in households. N. Engl. J. Med., 362, 2175–2184.
21. Zhang, X., He, J., Li, L., et al. (2011): Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study. PLoS One, 6, e23034.
17. Bin, C., Xingwang, L., Yuelong, S., et al. (2009): National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg. Infect. Dis., 15, 1418–1422.
6. World Health Organization (2009): World Now at the Start of 2009 Influenza Pandemic; statement to the press by WHO Director-General Dr Margaret Chan. Online at 〈http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html〉. Accessed 15 March 2010.
13. World Health Organization Collaborating Centers for Reference and Research on Influenza and United States. Dept. of Health and Human Services (1982): Concepts and Procedures for Laboratory-Based Influenza Surveillance. p. 17–35.
11. Miller, E., Hoschler, K., Hardelid, P., et al. (2010): Incidence of 2009 pandemic influenza A H1N1 infection in England: a crosssectional serological study. Lancet, 375, 1100–1108.
2. Centers for Disease Control and Prevention (2009): Outbreak of swine-origin influenza A (H1N1) virus infection—Mexico, March–April 2009. Morbid. Mortal. Wkly. Rep., 58, 467–470.
4. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Pandemic phase level 4: human cases of the novel influenza A/H1N1 strain confirmed in Scotland and Spain. Euro Surveillance, 14, pii: 19185.
19. Gilbert, G.L., Cretikos, M.A., Hueston, L., et al. (2010): Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One, 5, e12562.
1. Centers for Disease Control and Prevention (2009): Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. Mobid. Mortal. Wkly. Rep., 58, 400–402.
18. Chen, C.J., Lee, P.I., Chang, S.C., et al. (2011): Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS ONE, 6, e24440.
32. Zhou, Y., Ng, D.M.W., Seto, W.H., et al. (2011): Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J. Hosp. Infect., 78, 308–311.
7. Wu, J.T., Ma, E.S., Lee, C.K., et al. (2010): The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin. Infect. Dis., 51, 1184–1191.
25. Prachayangprecha, S., Makkoch, J., Vuthitanachot, C., et al. (2011): Epidemiological and serological surveillance of human pandemic influenza A virus infections during 2009–2010 in Thailand. Jpn. J. Infect. Dis., 64, 377–381.
27. Hung, I.F., To, K.K., Lee, C.K., et al. (2010): Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin. Infect. Dis., 51, 274–279.
3. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). Euro Surveillance, 14, 1–4.
23. Maltezou, H.C., Katerelos, P., Mavrouli, M., et al. (2011): Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece. Vaccine, 29, 6664–6669.
20. Bandaranayake, D., Huang, Q.S., Bissielo, A., et al. (2010): Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One, 5, e13211.
16. Presanis, A.M., De Angelis, D., et al. (2009): New York City Swine Flu Investigation Team. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PloS Med., 6, e1000207.
22
23
24
25
26
27
28
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 6. World Health Organization (2009): World Now at the Start of 2009 Influenza Pandemic; statement to the press by WHO Director-General Dr Margaret Chan. Online at 〈http://www.who.int/mediacentre/news/statements/2009/h1n1_pandemic_phase6_20090611/en/index.html〉. Accessed 15 March 2010.
– reference: 17. Bin, C., Xingwang, L., Yuelong, S., et al. (2009): National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group. Clinical and epidemiologic characteristics of 3 early cases of influenza A pandemic (H1N1) 2009 virus infection, People's Republic of China, 2009. Emerg. Infect. Dis., 15, 1418–1422.
– reference: 21. Zhang, X., He, J., Li, L., et al. (2011): Serologic survey of the pandemic H1N1 2009 virus in Guangdong Province, China: a cross sectional study. PLoS One, 6, e23034.
– reference: 25. Prachayangprecha, S., Makkoch, J., Vuthitanachot, C., et al. (2011): Epidemiological and serological surveillance of human pandemic influenza A virus infections during 2009–2010 in Thailand. Jpn. J. Infect. Dis., 64, 377–381.
– reference: 23. Maltezou, H.C., Katerelos, P., Mavrouli, M., et al. (2011): Seroepidemiological study of pandemic influenza H1N1 following the 2009–2010 wave in Greece. Vaccine, 29, 6664–6669.
– reference: 31. Rizzo, C., Rota, M.C., Bella, A., et al. (2010): Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine, 28, 3558–3562.
– reference: 26. Wu, U.I., Liu, M.T., Wang, J.T., et al. (2010): Serological response to H1N1 influenza virus infections in adults treated with oseltamivir. Clin. Infect. Dis., 51, 1223–1225.
– reference: 29. Hancock, K., Veguilla, V., Lu, X., et al. (2009): Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med., 361, 1945–1952.
– reference: 27. Hung, I.F., To, K.K., Lee, C.K., et al. (2010): Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin. Infect. Dis., 51, 274–279.
– reference: 30. Huang, D.T., Shao, P.L., Huang, K.C., et al. (2011): Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerg. Infect. Dis., 17, 76–78.
– reference: 28. Ross, T.M., Hairong, L., Chia, B.S., et al. (2011): Prevalence of antibodies against seasonal influenza A and B viruses during the 2009–2010 and 2010–2011 influenza seasons in residents of Pittsburgh, PA, USA. PLoS Currents Influenza, 2011 Oct 25.
– reference: 2. Centers for Disease Control and Prevention (2009): Outbreak of swine-origin influenza A (H1N1) virus infection—Mexico, March–April 2009. Morbid. Mortal. Wkly. Rep., 58, 467–470.
– reference: 32. Zhou, Y., Ng, D.M.W., Seto, W.H., et al. (2011): Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong. J. Hosp. Infect., 78, 308–311.
– reference: 9. Tilston, N.L., Eames, K.T., Paolotti, D., et al. (2010): Internetbased surveillance of influenza-like-illness in the UK during the 2009 H1N1 influenza pandemic. BMC Public Health, 10, 650.
– reference: 11. Miller, E., Hoschler, K., Hardelid, P., et al. (2010): Incidence of 2009 pandemic influenza A H1N1 infection in England: a crosssectional serological study. Lancet, 375, 1100–1108.
– reference: 7. Wu, J.T., Ma, E.S., Lee, C.K., et al. (2010): The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin. Infect. Dis., 51, 1184–1191.
– reference: 14. Word Health Organization (WHO): WHO Manual on animal influenza diagnosis and surveillance WHO/CDS/CSR/NCS/2002.5. Online at 〈http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf〉.
– reference: 19. Gilbert, G.L., Cretikos, M.A., Hueston, L., et al. (2010): Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One, 5, e12562.
– reference: 5. Centers for Disease Control and Prevention (2009): Swine-origin influenza A (H1N1) virus infections in a school—New York City, April 2009. Mobid. Mortal. Wkly. Rep., 58, 470–472.
– reference: 20. Bandaranayake, D., Huang, Q.S., Bissielo, A., et al. (2010): Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One, 5, e13211.
– reference: 22. Achonu, C., Rosella, L., Gubbay, J.B., et al. (2011): Seroprevalence of pandemic influenza H1N1 in Ontario from January 2009–May 2010. PLoS One, 6, e26427.
– reference: 24. von Kries, R., Weiss, S., Falkenhorst, G., et al. (2011): Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children, 18 years in Germany. PLoS One, 6, e23955.
– reference: 4. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Pandemic phase level 4: human cases of the novel influenza A/H1N1 strain confirmed in Scotland and Spain. Euro Surveillance, 14, pii: 19185.
– reference: 18. Chen, C.J., Lee, P.I., Chang, S.C., et al. (2011): Seroprevalence and severity of 2009 pandemic influenza A H1N1 in Taiwan. PLoS ONE, 6, e24440.
– reference: 13. World Health Organization Collaborating Centers for Reference and Research on Influenza and United States. Dept. of Health and Human Services (1982): Concepts and Procedures for Laboratory-Based Influenza Surveillance. p. 17–35.
– reference: 15. Cowling, B.J., Chan, K.H., Fang, V.J., et al. (2010): Comparative epidemiology of pandemic and seasonal influenza A in households. N. Engl. J. Med., 362, 2175–2184.
– reference: 3. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Initial epidemiological findings in the European Union following the declaration of pandemic alert level 5 due to influenza A (H1N1). Euro Surveillance, 14, 1–4.
– reference: 10. European Centre for Disease Prevention and Control Technical Emergency Team (2009): Progression and impact of the first winter wave of the 2009 pandemic H1N1 influenza in New South Wales, Australia. Euro Surveillance, 14, pii=19365.
– reference: 1. Centers for Disease Control and Prevention (2009): Swine influenza A (H1N1) infection in two children—Southern California, March–April 2009. Mobid. Mortal. Wkly. Rep., 58, 400–402.
– reference: 12. Xu, C., Bai, T., Iuliano, A.D., et al. (2010): The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One, 6, e17919.
– reference: 16. Presanis, A.M., De Angelis, D., et al. (2009): New York City Swine Flu Investigation Team. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PloS Med., 6, e1000207.
– reference: 8. Zimmer, S.M., Crevar, C.J., Carter, D.M., et al. (2010): Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS ONE, 5, e11601.
– ident: 2
– ident: 7
  doi: 10.1371/journal.pone.0011601
– ident: 20
  doi: 10.1371/journal.pone.0023034
– ident: 4
– ident: 3
  doi: 10.2807/ese.14.18.19204-en
– ident: 12
– ident: 27
  doi: 10.3201/eid1701.100014
– ident: 16
– ident: 24
  doi: 10.1086/656922
– ident: 17
  doi: 10.1371/journal.pone.0024440
– ident: 28
  doi: 10.1016/j.vaccine.2010.03.006
– ident: 9
– ident: 14
  doi: 10.1056/NEJMoa0911530
– ident: 22
– ident: 5
– ident: 10
  doi: 10.1016/S0140-6736(09)62126-7
– ident: 1
– ident: 11
– ident: 18
  doi: 10.1371/journal.pone.0012562
– ident: 8
  doi: 10.1186/1471-2458-10-650
– ident: 13
– ident: 15
– ident: 26
  doi: 10.1056/NEJMoa0906453
– ident: 19
  doi: 10.1371/journal.pone.0013211
– ident: 6
– ident: 21
– ident: 25
– ident: 23
SSID ssj0025510
Score 1.911731
Snippet The purpose of this study was to understand the geographic extent, risk factors, and attack rate of the 2009 pandemic influenza A (H1N1) virus [A(H1N1)pdm09]...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 410
SubjectTerms Adolescent
Adult
Antibodies, Viral - blood
Child
Child, Preschool
China - epidemiology
Cross-Sectional Studies
Female
Humans
Infant
Influenza A Virus, H1N1 Subtype - immunology
Influenza A Virus, H1N1 Subtype - isolation & purification
Influenza Vaccines - administration & dosage
Influenza, Human - epidemiology
Influenza, Human - immunology
Influenza, Human - virology
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Pandemics - statistics & numerical data
Seroepidemiologic Studies
Vaccination - statistics & numerical data
Title Post-Pandemic Seroprevalence of 2009 Pandemic Influenza A (H1N1) Virus in Shandong Province, China
URI https://www.jstage.jst.go.jp/article/yoken/65/5/65_410/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/22996214
https://www.proquest.com/docview/1069205826
https://www.proquest.com/docview/1534857791
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Japanese Journal of Infectious Diseases, 2012, Vol.65(5), pp.410-414
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9QwFA66ivgiXtfxRgQFZe04vaRtHhdRB3EXwV2Yt9KEdHe8tMMyI-7-er-TpJkLjqgvnaE5bUrOl-Sck3Nh7JmiHCxFqqMmkSLKZGYiSgESmaI0SjSyiRUFOB8c5uPj7MNETJYnuja6ZK6G-uK3cSX_w1XcA18pSvYfOBteihv4D_7iCg7j-lc8pkq70YzMwOThji6ppAk6sLMVUiCdSeyF9qmrR3JRYzGAXDmOD2OyCfyYni2sU-xnMqJT6aFP1szgrOuhvnaQYLG7UtXK9ZwTzqML7_EHPkFS_zhdOEgsb9jzkNPOb5lk3fFuwfiA7uc07BNLW_apaU_Oa_-AN1F4t2jjFtSyzCKIMPnqiuuqQ3hkiZXlM3MurpvLOtR0Si9x3n017TAXww0yMGX23bI4weaaJy4qdSONdt90mV1JiiIm78_3k-ANBMUqHrm4COrs9WpXlC_aP7wmvFz9Avn9xGxXTayIcnST3fC6Bd93QLnFLpn2Nrt24L0n7jC1hhe-jhfeNZzwwkN7wAvf5y8ILS-5xQoaeI8V3mPlFbdIucuO3709ejOOfI2NSAuZzKOibspapzlGQDci16UyRTIqZK6UbkhflXUdN5mWEOxk02SZEhoquRYp9FDIMuk9ttN2rbnPuFQmVqPUyBpirsSPoSJ2VkAUdHPA9vrBq7RPQE91UL5VUERp1Cs76lUuKoz6gD0P1DOXeGULXen4EKj8dFxSCU8aWiigEevHgD3tOVdhUaWTMkwgzBV0lMtkJKB6_4FGpFkpikLGA7br2B4-ocfLg60tD9l1minOmPeI7czPFuYxxNu5emKB-Qu2aaYl
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Post-pandemic+seroprevalence+of+2009+pandemic+influenza+A+%28H1N1%29+virus+in+Shandong+Province%2C+China&rft.jtitle=Japanese+journal+of+infectious+diseases&rft.au=Liu%2C+Ti&rft.au=Li%2C+Zhong&rft.au=Song%2C+Shaoxia&rft.au=Zhang%2C+Shengyang&rft.date=2012&rft.eissn=1884-2836&rft.volume=65&rft.issue=5&rft.spage=410&rft_id=info:doi/10.7883%2Fyoken.65.410&rft_id=info%3Apmid%2F22996214&rft.externalDocID=22996214
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1344-6304&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1344-6304&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1344-6304&client=summon